Covenant Logistics Group (CVLG, $28.08) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Inhibrx Biosciences (INBX, $82.16) Aroon Indicator entered an Uptrend on February 12, 2026.
Tickeron - Stocks
Inhibrx Biosciences (INBX, $82.16) Stochastic Oscillator left the overbought zone on February 12, 2026
Tickeron - Stocks
Sol-Gel Technologies (SLGL, $75.45) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 12, 2026
Tickeron - Stocks
Solid Biosciences (SLDB, $6.07) price may climb as it broke lower Bollinger Band on Feb 12, 2026
Tickeron - Stocks
Solid Biosciences (SLDB, $6.07) Aroon Indicator entered an Uptrend on February 12, 2026.
Tickeron - Stocks
Sol-Gel Technologies (SLGL, $75.45) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Twist Bioscience (TWST, $47.68) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Navios Maritime Partners (NMM, $60.33) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
FreightCar America (RAIL, $12.83) Aroon Indicator entered an Uptrend on February 12, 2026.
Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $28.11) entered Uptrend as Momentum indicator ascends above 0 level on Feb 12, 2026
Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $28.11) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 12, 2026
Tickeron - Stocks
Radiant Logistics (RLGT, $7.61) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Innospec (IOSP, $86.73) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Align Technology (ALGN, $183.86) RSI Indicator left the overbought zone on February 12, 2026
Tickeron - Stocks
Emergent Biosolutions (EBS, $10.85) Aroon Indicator entered a Downtrend on February 12, 2026.
Tickeron - Stocks
Regulatory Delays Threaten Agios Pharmaceuticals' Drug Pipeline, Costs and Revenue Outlook
TipRanks Financial Blog
Pilgrim's Pride Faces Rising Operational Risks Amid Battle to Attract and Retain Key Talent
TipRanks Financial Blog
WAT Q4 Deep Dive: Acquisition Integrates BD Biosciences, Margin Pressures Offset Revenue Growth
StockStory Articles
Has Ligand Pharmaceuticals (LGND) Run Too Far After Its 59% One-Year Share Price Surge?
Simply Wall St
Samsung's non-memory unit to turn profitable in 4Q26 as Exynos 2700 targets 50% share in Galaxy S27
DigiTimes: IT news from Asia
Xiaomi Watch 5 EU pricing leaks
GSMArena
